COPPINI, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.709
EU - Europa 6.812
AS - Asia 3.620
SA - Sud America 602
AF - Africa 73
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.620
PL - Polonia 2.150
RU - Federazione Russa 1.987
SG - Singapore 1.069
IT - Italia 1.021
CN - Cina 902
HK - Hong Kong 601
BR - Brasile 486
IE - Irlanda 418
KR - Corea 336
SE - Svezia 302
VN - Vietnam 280
DE - Germania 212
FI - Finlandia 134
GB - Regno Unito 131
IN - India 116
JO - Giordania 103
FR - Francia 102
CH - Svizzera 91
ID - Indonesia 87
UA - Ucraina 63
AR - Argentina 48
AU - Australia 45
NL - Olanda 43
CA - Canada 40
BE - Belgio 38
ES - Italia 38
MX - Messico 31
BD - Bangladesh 24
ZA - Sudafrica 24
JP - Giappone 21
EC - Ecuador 20
CI - Costa d'Avorio 19
GR - Grecia 16
VE - Venezuela 13
IQ - Iraq 12
LT - Lituania 11
RO - Romania 11
TR - Turchia 11
AT - Austria 9
MA - Marocco 9
PE - Perù 7
PK - Pakistan 7
CL - Cile 6
CO - Colombia 6
PH - Filippine 6
PY - Paraguay 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
KE - Kenya 5
KZ - Kazakistan 5
PT - Portogallo 5
BJ - Benin 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HU - Ungheria 4
KW - Kuwait 4
NO - Norvegia 4
UY - Uruguay 4
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
MK - Macedonia 2
MU - Mauritius 2
NI - Nicaragua 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
Totale 18.855
Salva come PNG Salva come JPEG
Città #
Warsaw 2.140
Santa Clara 1.707
Ashburn 750
Fairfield 745
Singapore 727
Hong Kong 525
Dublin 406
Chandler 375
Woodbridge 344
Seoul 332
Seattle 322
Cambridge 297
Florence 295
Houston 262
Beijing 248
Wilmington 244
Hefei 226
Ann Arbor 217
Lawrence 128
Munich 125
Altamura 124
Buffalo 121
Dallas 115
Los Angeles 99
Princeton 99
Bern 85
Ho Chi Minh City 81
Moscow 79
New York 78
Mumbai 75
Jakarta 67
Boston 65
Dong Ket 57
Medford 56
San Diego 56
Shanghai 55
São Paulo 50
Rome 47
Kent 46
Hanoi 45
Melbourne 44
Milan 44
Turku 43
Boardman 42
Clifton 41
Brussels 35
Falls Church 35
Helsinki 35
The Dalles 33
London 28
Barcelona 27
Paris 27
Frankfurt am Main 26
Redondo Beach 24
Norwalk 23
Rio de Janeiro 23
Chicago 22
Bologna 21
Phoenix 21
Abidjan 19
Lappeenranta 19
Andover 17
Dearborn 17
Montreal 17
Redwood City 17
Scandicci 17
Johannesburg 16
Tokyo 16
Guangzhou 15
Bengaluru 14
Toronto 14
Denver 13
Falkenstein 13
Hillsboro 12
Poplar 12
Mexico City 11
Yubileyny 11
Brasília 10
Orem 10
Poggio A Caiano 10
Tianjin 10
Brooklyn 9
Chennai 9
Nanjing 9
Redmond 9
Siena 9
Belo Horizonte 8
Guarulhos 8
Nuremberg 8
Washington 8
Amsterdam 7
Atlanta 7
Biên Hòa 7
Da Nang 7
Guayaquil 7
Las Vegas 7
Naples 7
Perugia 7
Turin 7
Ankara 6
Totale 12.965
Salva come PNG Salva come JPEG
Nome #
Ipertensione arteriosa LINEE GUIDA REGIONE TOSCANA 513
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 424
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 374
Atrial Remodeling in Hypertrophic Cardiomyopathy 363
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 337
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 312
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 296
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 285
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 279
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 262
Oleuropein aglycone protects against MAO-A-induced autophagy impairment and cardiomyocyte death through activation of TFEB. 262
Electrical defects of the transverse-axial tubular system in cardiac diseases 253
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 252
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 249
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 247
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 238
A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study 233
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 232
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 224
Design of muscle contraction assist devices by liquid crystalline elastomers 217
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 211
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 206
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 203
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 196
Arrhythmia susceptibility in a rat model of acute atrial dilation 194
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 193
Real-time optical manipulation of cardiac conduction in intact hearts 192
Action potential propagation in transverse-axial tubular system is impaired in heart failure 187
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 187
Impact of Mavacamten on Force Generation in Single Myofibrils from Rabbit Psoas and Human Cardiac Muscle 184
EFFECTS OF MAVACAMTEN, A FIRST-IN-CLASS INHIBITOR OF SARCOMERIC MYOSINS, ON THE MECHANICS OF ATRIAL AND VENTRICULAR MAMMALIAN MYOCARDIUM AND FAST SKELETAL MUSCLE 184
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 181
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 180
Representativeness of the "Fiesole Misurata" study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications 179
The transverse-axial tubular system of cardiomyocytes. 177
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 175
Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives 173
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 173
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 172
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] 167
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 164
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 164
Impact of detubulation on force and kinetics of cardiac muscle contraction 162
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 162
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 161
R4496C RyR2 mutation impairs atrial and ventricular contractility 160
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 159
Functional cardiac imaging by random access microscopy 158
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 157
Whole heart cytoarchitecture at micron-scale resolution 156
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 156
Optical clearing in cardiac imaging: A comparative study 156
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial 154
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 150
Time resolved depression of isometric force by Mavacamten in single myofibrils from rabbit psoas and human cardiac muscle 149
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study 149
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 148
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 147
Cardiomyocyte-specific Gq signalling and arrhythmias: Novel insights from DREADD technology 147
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 145
Mavacamten depresses human atrial contractility in the same EC50% range as human ventricle 144
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 142
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 142
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 141
Impact of RyR2 mutation responsible for Cathecolaminergic Polymorphic Ventricular Tachycardia (CPTV) on the short term interval-force relationship of atrial and ventricular myocardium 137
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 137
Altered calcium regulation in isolated cardiomyocytes from Egr-1 knock-out mice 137
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 136
Contraction and electrophysiological abnormalities in myofilament mutation-positive and mutation-negative human HCM myocardium 134
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex 132
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 132
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 132
Impact of R4496C RyR2 mutation on myocardial contractility 132
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 131
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 131
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 131
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations 131
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 131
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 129
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 129
Neural Effects on Cardiac Electrophysiology 128
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 128
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study 128
Clinical research in neonates and infants: Challenges and perspectives 127
Structural Mapping of Action Potential Propagation Pathways through Healthy and Diseased Heart 125
Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy 121
Electrophysiological and molecular remodeling in septal myocytes from fHCM patients 120
Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle 120
Targets for therapy in sarcomeric cardiomyopathies. 119
Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy 117
Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018 Abstracts 116
Letter to the Editor 115
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 114
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside 114
Channelopathies, cardiac hypertrophy, and the theory of light 112
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 111
T-tubule remodeling in human hypertrophic cardiomyopathy 111
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 110
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 109
Novel pharmacological approaches for paediatric hypertrophic cardiomyopathy 106
Totale 17.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.125 0 0 0 0 0 140 113 135 151 403 90 93
2021/2022902 41 49 78 41 50 51 51 46 49 65 149 232
2022/20232.020 178 365 105 126 122 310 236 104 273 30 65 106
2023/2024911 37 92 112 38 55 129 53 186 18 59 51 81
2024/20255.802 241 668 378 817 1.480 703 136 389 298 139 246 307
2025/20264.037 725 964 669 821 835 23 0 0 0 0 0 0
Totale 19.073